Literature DB >> 12472282

Paranuaclear E-cadherin in gastric adenocarcinoma.

Philip M Carpenter1, Rasha A Al-Kuran, Charles P Theuer.   

Abstract

Decreased E-cadherin expression permits dissociation and widespread dissemination of gastric adenocarcinoma cells. We studied the relationship between paranuclear E-cadherin distribution and the histopathologic characteristics of gastric adenocarcinomas. E-cadherin immunostains of 173 gastric adenocarcinoma sections revealed paranuclear; punctate to vesicular staining in 18% (16/87) of the intestinal-type adenocarcinomas, 30% (17/56) of the diffuse-type adenocarcinomas, and 30% (9/30) of the mired adenocarcinomas. These data suggest that in some gastric adenocarcinomas, there is a defect in transport of E-cadherin to the cell surface, which may prevent intercellular adhesion and encourage dissemination. Of 34 cancers with paranuclear E-cadherin staining, 20 (59%) had paranuclear staining within the nonneoplastic epithelium, but only 22.0% of 100 carcinomas with absent or membranous E-cadherin staining were accompanied by morphologically benign epithelium with paranuclear E-cadherin. In surface epithelium, paranuclear E-cadherin staining colocalized with Griffonia simplicifolia lectin II in the Golgi apparatus. The presence of paranuclear E-cadherin in cancer-associated benign epithelium suggests that the alteration in the E-cadherin molecule responsible for the paranuclear distribution may be an early change in gastric adenocarcinoma progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12472282     DOI: 10.1309/EKFB-0HJT-AB1D-5LJB

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.

Authors:  Poulomi Banerjee; Harshini Surendran; Debabani Roy Chowdhury; Karthik Prabhakar; Rajarshi Pal
Journal:  J Mol Med (Berl)       Date:  2016-08-17       Impact factor: 4.599

2.  DNA ploidy analysis and expression of MMP-9, TIMP-2, and E-cadherin in gastric carcinoma.

Authors:  Jing-Fang Zhang; Yuan-Ping Zhang; Feng-Yun Hao; Cai-Xin Zhang; Yu-Jun Li; Xiang-Rui Ji
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

3.  E-Cadherin Modulation and Inter-Cellular Trafficking in Tubular Gastric Adenocarcinoma: A High-Resolution Microscopy Pilot Study.

Authors:  Ilona Mihaela Liliac; Bogdan Silviu Ungureanu; Claudiu Mărgăritescu; Victor Mihai Sacerdoțianu; Adrian Săftoiu; Laurențiu Mogoantă; Emil Moraru; Daniel Pirici
Journal:  Biomedicines       Date:  2022-02-01

4.  A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype.

Authors:  Andrew J Syder; Sherif M Karam; Jason C Mills; Joseph E Ippolito; Habib R Ansari; Vidya Farook; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

5.  A protein and mRNA expression-based classification of gastric cancer.

Authors:  Namrata Setia; Agoston T Agoston; Hye S Han; John T Mullen; Dan G Duda; Jeffrey W Clark; Vikram Deshpande; Mari Mino-Kenudson; Amitabh Srivastava; Jochen K Lennerz; Theodore S Hong; Eunice L Kwak; Gregory Y Lauwers
Journal:  Mod Pathol       Date:  2016-04-01       Impact factor: 7.842

6.  α-Catenin contributes to the strength of E-cadherin-p120 interactions.

Authors:  Regina B Troyanovsky; Jörg Klingelhöfer; Sergey M Troyanovsky
Journal:  Mol Biol Cell       Date:  2011-09-21       Impact factor: 4.138

7.  Aberrant E-cadherin staining patterns in invasive mammary carcinoma.

Authors:  Malini Harigopal; Sandra J Shin; Melissa P Murray; Satish K Tickoo; Edi Brogi; Paul Peter Rosen
Journal:  World J Surg Oncol       Date:  2005-11-14       Impact factor: 2.754

8.  RhoA, Claudin 18, and c-MET in Gastric Cancer: Clinicopathological Characteristics and Prognostic Significance in Curative Resected Patients.

Authors:  Marina Alessandra Pereira; Marcus Fernando Kodama Pertille Ramos; Andre Roncon Dias; Leonardo Cardili; Renan Ribeiro E Ribeiro; Tiago Biachi de Castria; Bruno Zilberstein; Sergio Carlos Nahas; Ulysses Ribeiro; Evandro Sobroza de Mello
Journal:  Med Sci (Basel)       Date:  2021-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.